Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Battle of the Luxury Automakers
17:35 - In today's "Brandstanding" segment, Simon Sproule, director of global marketing communications at Aston Martin Lagonda, discusses the Aston Martin brand, the "Bond effect," and how they market to a younger generation. He speaks to Bloomberg's Haslinda Amin on "Trending Business." (Source: Bloomberg)
  • Japan Economy: Will More Monetary Stimulus Matter?
  • Singapore Aims to Revive Tourism Numbers
  • The Top Three Stocks to Watch in Asia Today